Abstract
Differences in COVID-19 infection and clinical outcomes between adults with and without ADHD are well documented. Less is known about disparities in their broader pandemic experiences or the extent to which substance use and socioeconomic resources contributed to these differences. Heightened isolation and psychological distress during the pandemic may have intensified ADHD-related stress and emotional instability, increasing reliance on coping strategies with health risks, such as substance use. Moreover, adults with ADHD often face structural disadvantages resulting in less robust socioeconomic resources to protect against pandemic stressors. Using data from the 2023 National Wellbeing Survey – a nationally representative sample of U.S. working-age adults aged 25–64 (N=5,725) – we examined ADHD-related differences in overall COVID-19 experiences and five specific domains: financial situation, physical health, mental health, relationships with family, and relationships with friends. We used regression and the Karlson–Holm–Breen method to assess the contribution of substance use and socioeconomic resources to these differences. Net of controls, adults with ADHD were significantly more likely to report adverse COVID-19-related experiences overall and across health and relationship domains. Adjusting for substance use and socioeconomic resources attenuated these differences, accounting for 9.5% to 23.8% of the differences between adults with versus without ADHD. These findings highlight the importance of recognizing how large-scale shocks like the COVID-19 pandemic can lead to adverse outcomes among people with ADHD.
Keywords: COVID-19, ADHD, substance use, SES, adults
1.1. Introduction
The COVID-19 pandemic was a major public health crisis that created profound stressors for communities, institutions, and individuals, and contributed to individual-level psychosocial strain (Bridgland et al., 2021). Prolonged uncertainty and restrictive measures disrupted multiple systems and aspects of daily life (Pendergrast & Monnat, 2022). Like earlier epidemics, COVID-19 revealed how “ideology, social structure, and the construction of particular selves” intersect (Rosenberg, 1989, p. 2; Braksmajer & London, 2021). Importantly, pandemic outcomes and responses varied across demographic and socioeconomic groups and along other dimensions of vulnerability (Biswas et al., 2021; Landes et al., 2022; Pendergrast & Monnat, 2022).
Individuals with attention-deficit/hyperactivity disorder (ADHD) may have been particularly vulnerable to pandemic-related disruptions and hardships (Pollak et al., 2022). It is estimated that 6.0% of U.S. adults, representing over 15 million individuals, self-reported a current diagnosis of ADHD in 2023 (Staley et al., 2024). Lifetime estimates of ever being diagnosed with ADHD are higher, with one recent study estimating that 13.9% of working-age adults had ever been diagnosed (London et al., 2025a). ADHD is a prevalent, life-long neurodevelopmental disability characterized by persistent inattention, hyperactivity, and impulsivity that can impair executive functioning, self-regulation, and daily task management (Lensing et al., 2015). Roughly 60% of those diagnosed in childhood continue to experience symptoms into adulthood (Sibley et al., 2017). Importantly, ADHD symptoms and their effects on functioning often intensify during periods of high stress and environmental instability (Hollingdale et al., 2021).
The COVID-19 pandemic disrupted daily routines, social structures, and institutional supports, posing particular challenges for adults whose capacity for self-regulation, time management, and adaptation to changing conditions was already strained (Hollingdale et al., 2021). Adults with ADHD rely heavily on stimulant medication and behavioral interventions to manage core symptoms. Thus, disruptions to regular healthcare access, combined with heightened social stressors, such as household crowding, changes in work routines, and loss of access to friends and sexual partners, may have increased vulnerability to behaviors with health risks, such as substance use (Barra et al., 2021). Compared to adults without ADHD, adults with ADHD have significantly higher lifetime and past-year rates of illicit drug use and prescription medication misuse (London et al., 2025b), which may have placed them at greater risk of adverse outcomes during a period of heightened pandemic-related stress.
Effective stress management and coping often depend on having robust social and professional supports. Timely interventions, including pharmacological and non-pharmacological treatments, alongside emotional and social support, can substantially mitigate ADHD-related symptoms and promote both mental and physical wellbeing (Connolly et al, 2023; López-Pinar et al, 2018). However, adults with ADHD often have limited access to these resources due to structural barriers associated with lower socioeconomic status (SES). Compared to adults without ADHD, adults with ADHD are more likely to experience lower educational attainment (Varrasi et al., 2023), unstable employment (Schein et al., 2022), reduced access to medical care (Swift et al., 2014), challenges with interpersonal relationships (Segal et al, 2015; Wymbs et al. 2021), and pervasive stigma (Metzger & Hamilton, 2021). These disadvantages function as social determinants of health that accumulate across the life course, amplifying ADHD-related stress and compounding challenges in managing social relationships, finances, and health. As a result, adults with ADHD face numerous health disadvantages and elevated risks for a range of comorbid mental and physical health conditions (Landes & London, 2021; Quenneville et al., 2022).
The clustering of SES- and health-related disadvantages among adults with ADHD may have increased their vulnerability to COVID-19-related challenges. Pandemic-related disruptions reduced healthcare access and weakened support systems, which likely compounded existing challenges. While international research has documented negative pandemic-related financial and health outcomes among adults with ADHD (Pollak et al., 2022), U.S. studies have focused on clinical outcomes, education, employment, and access to medications and healthcare (Rao et al., 2025; Tuan et al., 2022). No U.S. study has examined whether ADHD among working-age adults is associated with worse COVID-19 experiences across multiple life domains simultaneously.
A multi-domain examination that includes financial, health, and social outcomes is important for several reasons. First, it allows us to test whether adverse pandemic experiences were concentrated in specific areas (e.g., only mental health) or instead reflected systematic, multi-dimensional disadvantage – a pattern that would suggest broader structural vulnerabilities during large-scale disruptions. Second, examining multiple life domains allows us to assess whether ADHD-related disparities in COVID outcomes were driven by shared or domain-specific mechanisms. Third, using a neurodiversity-affirming stress process framework, this study conceptualizes ADHD-related disparities during the COVID-19 pandemic as arising from interactions between neurodivergence-related symptoms and characteristics and pandemic-related societal instability, with substance use and socioeconomic resources as potential mechanisms. To achieve these objectives and address gaps in the literature, the present study aims to: (1) comparing COVID-19 experiences between U.S. working-age adults with and without a self-reported ADHD diagnosis, overall and with respect to five distinct life domains: financial wellbeing, mental and physical health, and relationships with family and friends; and (2) exploring the extent to which ADHD-related variation in substance use and socioeconomic resources contributed to these differences.
1.2. Background
1.2.1. Intersecting stresses: ADHD status and COVID‑19
The stress process model helps explain how broader social contexts influence coping strategies, emphasizing the interplay between structural conditions, stress exposure, human agency, and available resources in relation to health and wellbeing (Pearlin & Bierman, 2012). The COVID-19 pandemic was a “macro-level stressor” (Ciciurkaite et al., 2022) that generated “constellations of secondary stressors” (Pearlin & Bierman, 2012, 16), including heightened health risks, reduced access to health care, social isolation, job loss, and financial uncertainty. These structural conditions and stressors disproportionally affected economically and socially disadvantaged groups, including people with disabilities (Ciciurkaite et al., 2022; Hollingdale et al., 2021).
While research has documented negative pandemic impacts among people with disabilities broadly (Landes et al., 2022; Pendergrast & Monnat, 2022), adults with ADHD may face theoretically distinct challenges during large-scale crises. Unlike disabilities that primarily affect physical mobility or sensory processing, ADHD often impacts executive functioning, which can result in difficulties with planning, organization, impulse control, and memory that become particularly consequential when external structure and routine are disrupted (Barra et al., 2021). Pandemic-related disruptions blurred work and family roles, increasing stress and strain and contributing to adverse mental and physical health outcomes (Pearlin & Bierman, 2012). Adults with ADHD faced higher risks of COVID-19 infection, severe symptoms, and hospitalization than peers without ADHD (Merzon et al., 2021; Pollak et al., 2022). Therefore, from a stress process perspective, the pandemic may have functioned as a macro-level stressor that triggered stress proliferation, generating secondary stressors (Pearlin & Bierman, 2012), which in turn may have amplified ADHD-symptom-related challenges.
1.2.2. Substance use as an alternative and potentially harmful coping strategy
Individuals respond to stress by engaging in various coping behaviors (Pearlin et al., 1981), with some strategies worsening rather alleviating strain (Pearlin et al., 1981; Pearlin & Bierman, 2012). Individuals with ADHD have higher rates of illicit drug use, prescription medication misuse, marijuana use, alcohol misuse, and tobacco use compared with those without ADHD (Barra et al., 2021; Holborn et al., 2025; London et al. 2025b). These patterns may partly reflect attempts to self-medicate ADHD symptoms (Holborn et al., 2025; Turner et al., 2018). While substance use may offer temporary relief, it carries substantial health and social risks. Chronic use is linked to poorer social relationships (Leonard & Eiden, 2007) and adverse health outcomes. For individuals with ADHD, the consequences may be especially harmful, as substance use can further impair executive functioning, exacerbate emotional dysregulation, and heighten inattention (Turner et al., 2018).
Pandemic-related increases in isolation and psychological distress (Bridgland et al., 2021) combined with disruptions to daily routines and access to prescription stimulants (Gimbach et al., 2024) may have amplified ADHD-related stresses and emotional instability. For adults with ADHD who were already engaged in substance use, these compounding stressors may have intersected with pre-existing vulnerabilities, contributing to adverse pandemic outcomes. Substance use can undermine self-regulation, reinforcing a cycle in which distress and harmful coping exacerbate one another (Brockett et al., 2018). Interruptions in supply chains and behavioral interventions during the pandemic may have led to changes in the types of substances used, frequency or intensity of use, or heightened stress associated with procurement. Additionally, substance use may have complicated access to care, disrupted treatment continuity, or increased exposure to other pandemic-related risks. Consistent with this pattern, research confirms that the pandemic created a highly stressful context that intensified existing vulnerabilities and contributed to potentially harmful coping among individuals with ADHD (Danielsson et al., 2024).
1.2.3. Socioeconomic determinants
The stress process model holds that individuals’ exposure to stress is embedded in social structures and varies systematically across social status groups (Pearlin & Bierman, 2012). Access to social and material resources affects the extent to which individuals can avoid, mitigate, and manage stress (Pearlin & Bierman, 2012). During major disruptions, such as the COVID-19 pandemic, people rely on social and material resources to buffer and manage distress (Pearlin et al., 1981; Pearlin & Bierman, 2012). Differential access to social and material resources by ADHD status may have affected experiences of COVID-19 in multiple ways. The comparatively lower SES of adults with ADHD may have limited their ability to buffer or mitigate COVID-19 related stress. Adults with ADHD often have lower educational attainment (Varrasi et al., 2023). This education disadvantage often translates into higher unemployment rates, precarious employment, and lower income, all of which may have worsened pandemic-related outcomes (Hollingdale et al., 2021). During COVID-19, lower-SES individuals were more likely to work as essential workers in crowded, high-risk environments (Capasso et al., 2022).
Marriage/partnership may also provide resources that buffer adversity by allowing for income pooling and financial stabilization, and by offering emotional support that reduces distress and encourages protective behaviors, such as vaccination (Talbert & Hearne, 2022). Relative to adults without ADHD, adults with ADHD experience higher rates of marital conflict, separation, and divorce (Oncu & Kislak, 2022), which may limit their access to these protections. Consequently, they may have been more vulnerable to financial strain, poorer health, and weakened social relationships during the pandemic.
1.3. The current study
This study describes: (1) differences in self-reported overall and domain-specific (physical and mental health, finances, and relationships with family and friends) COVID-19 experiences between U.S. working-age adults (25–64 years) with versus without a self-reported ADHD diagnosis; and (2) identifies how substance use (illicit drug use, prescription medication misuse, marijuana use, heavy drinking, and smoking status) and socioeconomic resources (education, employment, income, marital/partnership status) contributed to these differences. Based on theory and prior evidence, we hypothesized that adults with ADHD would be more likely to report negative COVID-19 experiences, and that both substance use (i.e., harmful health behaviors) and SES disadvantage would contribute to explaining these associations.
2. Methodology
2.1. Data and sample
We analyzed data from the 2023 National Wellbeing Survey (NWS) (N=7,105) (Monnat et al., 2023). The NWS is an annual, national, cross-sectional survey of 18–64-year-old U.S. adults who can read English. NWS participants are recruited by, and the survey was administered through, Qualtrics Panels. Information about the NWS response rate and quality is included in the Online Appendix. See the 2023 Methodology Report (Monnat & Gutin, 2025) for additional details about the NWS design, sample recruitment, survey administration, response rate, and representativeness.
The NWS is appropriate for these analyses because it includes questions about ADHD diagnosis status and COVID-19 experiences, along with measures of substance use and socioeconomic resources. The 2023 survey was the first wave of the NWS to include a question about ADHD diagnosis status and the last year the NWS included questions about COVID-19 experiences.
2.2. Dependent variables
We examined six outcomes, which measure participants’ self-reported experiences with the COVID-19 pandemic. The NWS measured global COVID-19 impact by asking: “All things considered, what impact would you say the COVID-19 pandemic has had on your life?” The response options were: “the COVID-19 pandemic has…(1) had a negative impact on my life; (2) had a positive impact on my life; and (3) not really affected my life one way or the other.” We recoded positive or no impact=0 and negative impact=1.
The NWS also measured self-reported COVID-related changes in experiences across five life domains: financial situation, physical health, mental health, relationships with immediate family (e.g., spouse/partner, parents, children), and relationships with friends. Each of these used the same wording: “Compared to right before the COVID-19 pandemic began, please rate each of the following aspects of your life right now.” Responses were measured on a 5-point Likert scale: “substantially improved,” “somewhat improved,” “no change,” “somewhat worsened,” and “substantially worsened.” We recoded participants who reported “substantially improved,” “somewhat improved,” or “no change”=0 and those who reported “somewhat worsened” or “substantially worsened”=1. The rationale underlying our decision to dichotomize outcomes is detailed in the Analytic strategy section below.
2.3. Independent variable
The independent variable was self-reported ADHD diagnosis (hereinafter, ADHD status). The NWS asked: “Have you ever been told by a doctor, nurse, or other health care professional that you have any of the following medical conditions?” Participants were provided with a list of conditions including “ADHD or attention deficit disorder (ADD).” We coded participants who selected “Yes”=1 and those who selected “No”=0. The survey did not ask about timing of diagnosis or current symptoms.
2.4. Substance use
We coded smoking status as “never,” “former,” or “current” smoker. We coded heavy drinking=1 for males who consumed 15 or more drinks per week and for females who consumed eight or more drinks per week (Rana et al., 2025). We coded all other participants=0. We coded illicit drug use=1 for participants who used any of the following illicit drugs: powder cocaine, crack cocaine, methamphetamine, heroin, fentanyl, or hallucinogens. We coded all other participants=0. We coded prescription medication misuse=1 for participants who misused prescription medications (opioids, tranquilizers, sedatives, or stimulants) in the past 12 months, and all others=0. Misuse was defined in the survey as: “use of the medication either when it was not prescribed for the participant or when it was taken in a way that was not prescribed by a physician (i.e., the prescription medication was taken more frequently than prescribed, to get high, or by crushing pills to get the dose faster).” We coded marijuana use=1 for participants who used marijuana in the past 12 months, and all others=0. We treated marijuana as a separate variable due to its varying legal status across states (Carliner et al., 2017).
2.5. Socioeconomic resources
Socioeconomic resources included: marital/partnership status (married/partnered, divorced/separated/widowed, single/never married); education (less than high school, high school diploma or GED, associate degree/some college, bachelor’s degree or more); employment status (employed=1); and annual household income quartiles in 2022 (<=$24,999, $25,000–$49,999, $50,000–$74,999, and $75,000+).
2.6. Other covariates
We adjusted regression models for variables that may confound associations between ADHD status and COVID-19-related outcomes. We adjusted all models for age (continuous); sex (male, female); race-ethnicity (non-Hispanic [NH] White, NH Black, Hispanic (any race), NH Asian/Pacific Islander, and NH Mixed and Other Race), number of people in the household (range=1–10), health insurance status (insured=1), had a routine health care check-up within the last year (yes=1), and rural-urban county of residence measured using the U.S. Department of Agriculture’s Economic Research Service 2023 Rural-Urban Continuum Codes (RUCC).
Finally, research shows that adults with ADHD were more likely to contract COVID-19 than those without ADHD (Merzon et al., 2022). Because COVID-19 infection may harm multiple domains of life, including physical and mental health, finances, and personal relationships (Settersten et al., 2020), we controlled for ever having a COVID-19 infection. The NWS measured COVID-19 infection history using the item: “Which of the following experiences with coronavirus (COVID-19) applied to you?: ever “tested positive,” with response options “Yes”=1 and “No”=0.
We were cautious about including additional covariates for which temporal ordering was uncertain. Variables like current self-rated health, which could function as an outcome of both ADHD and the COVID-19 experiences that we include as dependent variables, pose a clear risk of collider bias (Angrist & Pischke, 2009; Wysocki et al., 2022). We did include COVID-19 infection history, given evidence that adults with ADHD faced elevated infection risk (Merzon et al., 2022) and that infection itself can independently harm multiple life domains (Settersten et al., 2020). We note, however, that the extent to which COVID-19 infection lies on the causal pathway between ADHD and adverse outcomes, its inclusion may attenuate estimated ADHD-related disparities.
2.7. Analytic strategy
As is standard when education is included as a focal variable of interest, we excluded individuals aged 18–24 because they might not have yet completed their education. We also excluded 20 participants who reported non-binary sex due to an insufficient number of observations. Finally, we excluded 398 (5.6%) participants with missing information on ADHD diagnosis status or any of the six outcomes. We used 20 multiple imputations by chained equations (MICE) (Graham et al., 2007) to account for missing responses on race-ethnicity (N=8), employment status (N=1), smoking status (N=3), marijuana use (N=1), annual household income (N=148), COVID-19 infection status (N=1), number of people in the household (N=10), health insurance status (N=100), and check-ups (N=142). We did not impute outcome variables to avoid increasing sampling variability (Allison, 2001). We also did not impute ADHD status because its missingness may not be random due to attentional difficulties or hesitancy in reporting, and the NWS lacks measures that would adequately account for these processes. Under such circumstances, achieving unbiased multiple imputation estimates might not be possible. Our final analytic sample included 5,725 participants with complete data (including imputed covariates). Participants who were excluded were significantly more likely than those with complete data to have the following characteristics: female, Hispanic, other race, single, never smoked, used illicit drugs, used marijuana, misused prescription medications, unemployed, uninsured, and had not had a check-up within the last year.
We present descriptive statistics overall and by self-reported ADHD diagnosis status. We estimate binary logistic regression models to examine associations between ADHD status and each of the six outcomes. We estimated average marginal effects (AMEs) for each outcome, defined as the difference in average predicted probabilities (described here in percentage points) between participants with ADHD versus those without ADHD. For each outcome, Model 1 includes ADHD status, Model 2 adds covariates, and Model 3 adds substance use and socioeconomic resources. We examined variance inflation factors (VIFs) to test for multicollinearity. All VIF values were below 2, except three categories of education with values below or equal to 3.50 (mean VIF=1.14), indicating low multicollinearity among the independent variables.
We used the Karlson–Holm–Breen (KHB) method to assess the extent to which substance use and socioeconomic resources account for observed ADHD status differences in outcomes. This method decomposes the net “effect” of ADHD, after other variables are controlled, into a “direct effect” and an “indirect effect” that operates through the substance use and socioeconomic resource variables. In models with binary outcomes, comparing coefficients across nested models can lead to biased estimates due to rescaling (Kohler et al., 2011). Rescaling occurs when the inclusion of additional variables affects the unobserved residual variance. The KHB method addresses this issue by adjusting for rescaling, holding the residual variance constant across models. This allows for a valid statistical decomposition of the total association into “direct” and “indirect” components, ensuring that observed changes in coefficients reflect meaningful differences in explanatory variables rather than shifts in scale. We used the khb command in Stata to estimate binary logistic regression models for each of the six COVID-19-related outcomes. These models are intended to examine associations rather than to establish causal relationships. Because the data do not include information on the timing of ADHD diagnosis, it is not possible to determine whether ADHD preceded the reported outcomes. Therefore, the “effects” referenced in the decomposition results represent statistical associations and should not be interpreted as evidence of causal relationships.
Before conducting multivariable analyses with the dichotomized outcomes, we ran ordered logistic regression models using the original ordinal scales of the COVID-19-related outcomes. Brant tests indicated violations of the proportional odds assumption for some covariates. For this reason, and because the KHB method does not support generalized logistic regression models, we proceeded with logistic regression analyses of dichotomized outcomes.
We weighted all analyses using the global survey weight that maximizes the national representativeness of the NWS (Monnat & Gutin, 2025). In regression analyses, we included clustered standard errors at the state level to account for the clustering of participants within states. We also conducted sensitivity analyses that included participants ages 18–24 and that used listwise deletion instead of imputation. We discuss those analyses after the main results. We performed all analyses using Stata 18.0 (StataCorp, College Station, TX).
3. Results
3.1. Description of the study sample
Table 1 presents descriptive statistics overall and by self-reported ADHD diagnosis status. Overall, 13.2% of adults aged 25–64 self-reported ever being diagnosed with ADHD by a healthcare professional. Compared to adults without ADHD, adults with ADHD were significantly more likely (p<.05) to report negative (versus neutral/positive) COVID-19 experiences across all six domains: overall negative impact on life (54.5% among those with ADHD versus 37.7% among those without ADHD), worsened financial situation (36.6% versus 30.6%), worsened physical health (43.3% versus 24.4%) and mental health (49.1% versus 25.5%), and worsened relationships with family (27.2% versus 14.2%) and friends (33.1% versus 17.9%).
Table 1.
Descriptive Statistics (% or Means [Std. Errors]) and T-Tests for All Study Variables for U.S. Adults Ages 25–64
| Variable | Total (%) | No ADHD (86.8%) | ADHD (13.2%) |
|---|---|---|---|
|
| |||
| DEPENDENT VARIABLES | |||
| Overall COVID-19 impact on life (Negative=1) | 39.9 | 37.7 | 54.5*** |
| Compared to right before the COVID-19 pandemic please rate each of the following aspects of your life right now: | |||
| Financial situation (Worsened=1) | 31.4 | 30.6 | 36.6* |
| Physical health (Worsened=1) | 26.9 | 24.4 | 43.3*** |
| Mental health (Worsened=1) | 28.6 | 25.5 | 49.1*** |
| Relationship with immediate family (Worsened=1) | 15.9 | 14.2 | 27.2*** |
| Relationships with friends (Worsened=1) | 19.9 | 17.9 | 33.1*** |
|
COVARIATES | |||
| Biological sex (Female=1) | 47.7 | 47.1 | 51.2 |
| Age (in years) | 43.9 (0.24) | 44.7 (0.26) | 38.7*** (0.59) |
| Race-ethnicity | |||
| Non-Hispanic White | 60.7 | 60.3 | 63.2 |
| Non-Hispanic Black | 11.7 | 12.1 | 9.1 |
| Hispanic (any race) | 16.9 | 17.0 | 15.8 |
| Non-Hispanic Asian/Pacific Islander | 7.5 | 8.0 | 4.4* |
| Non-Hispanic other/multiple race | 3.3 | 2.6 | 7.5 |
| Rural-urban continuum (county of residence) | |||
| Metro, 1 million or more population | 56.6 | 58.5 | 44.1*** |
| Metro, 250,000–1 million population | 15.7 | 14.6 | 22.4** |
| Metro, <250,000 population | 13.4 | 12.6 | 18.6* |
| Large nonmetro, adjacent to metro | 4.8 | 4.8 | 4.7 |
| Large nonmetro, not adjacent to metro | 1.5 | 1.4 | 2.2 |
| Medium nonmetro, adjacent to metro | 3.4 | 3.4 | 3.9 |
| Medium nonmetro, not adjacent to metro | 2.1 | 2.1 | 2.5 |
| Small nonmetro, adjacent to metro | 1.1 | 1.2 | 0.5** |
| Small nonmetro, not adjacent to metro | 1.3 | 1.3 | 1.2 |
| Ever had COVID-19 infection (Yes=1) | 42.2 | 41.3 | 47.9* |
| Number of people in the household | 2.91 (0.03) | 2.91 (0.03) | 2.92 (0.06) |
| Health insurance (Insured=1) | 91.6 | 91.7 | 91.3 |
| Routine healthcare checkup in the last 12 months (Yes=1) | 68.7 | 69.1 | 66.0 |
|
MEDIATORS | |||
| Substance Use | |||
| Smoking status | |||
| Never smoker | 46.0 | 48.0 | 32.6*** |
| Former smoker | 22.2 | 21.2 | 29.0** |
| Current smoker | 31.8 | 30.8 | 38.4** |
| Heavy drinking (Yes=1) | 4.3 | 4.4 | 3.2 |
| Illicit drug use in past 12 months (Yes=1) | 9.4 | 7.5 | 22.1*** |
| Prescription medication misuse in 12 months (Yes=1) | 5.8 | 4.5 | 14.1*** |
| Marijuana use in 12 months (Yes=1) | 29.2 | 26.2 | 48.5*** |
| Socioeconomic Resources | |||
| Educational attainment | |||
| Less than high school | 5.4 | 4.9 | 8.3** |
| High school diploma/GED | 21.6 | 21.1 | 25.0 |
| Associate degree/some college | 36.0 | 35.7 | 38.1 |
| Bachelor`s degree or more | 37.0 | 38.3 | 28.6** |
| Employment status (Employed) | 75.32 | 76.2 | 69.8* |
| Household Income in 2022 | |||
| Less $25K | 9.4 | 8.7 | 13.9*** |
| $25K–$49K | 22.0 | 21.9 | 22.5 |
| $50K–$74K | 23.6 | 23.8 | 22.9 |
| $75K+ | 45.0 | 45.7 | 40.7 |
| Marital status | |||
| Married/member of an unmarried couple | 66.6 | 67.2 | 63.1 |
| Divorced/separated/widowed | 10.1 | 9.9 | 10.9 |
| Single, never married | 23.3 | 22.9 | 26.0 |
SOURCE: National Wellbeing Survey, 2023 (N= 5,725). NOTES: ADHD = attention-deficit/hyperactivity disorder. Two-tailed t-tests, with asterisks indicating statistically significant differences by ADHD status:
p < 0.05;
p < 0.01;
p < 0.001. All analyses were weighted.
Demographic and other differences by ADHD status are also evident. Compared to adults without ADHD, adults with ADHD were younger and less likely to identify as Asian/Pacific Islander and live in large metro counties. They were more likely to live in medium and small metro counties. Adults with ADHD were also more likely to ever test positive for COVID-19 than adults without ADHD.
There were also significant differences in substance use, including higher rates of former smoking (29.0% among adults with ADHD versus 21.2% among adults without ADHD) and current smoking (38.4% versus 30.8%), illicit drug use (22.1% versus 7.5%), prescription medication misuse (14.1% versus 4.5%), and marijuana use (48.5% versus 26.2%) in the past year. In terms of socioeconomic resources, adults with ADHD were more likely to have less than a high school degree (8.3% versus 4.9%) and less likely to have a bachelor’s degree or higher (28.6% versus 38.3%). They were also less likely to be employed (69.8% versus 76.2%) and more likely to report a household income below $25,000 (13.9% versus 8.7%).
3.2. Multivariable analysis
Table 2 presents results from a set of binary logistic regression models, reported as average marginal effects (AMEs), predicting the probability of reporting each outcome. Odds ratios with 95% confidence intervals are presented in Online Appendix Tables 1-6. The unadjusted model (Model 1) shows that adults with ADHD were significantly more likely than adults without ADHD to report each of the negative COVID-19 experiences. In unadjusted analyses, the predicted probability of experiencing a negative outcome was between 6 and 24 percentage points higher among adults with ADHD, depending on the outcome.
Table 2.
Average Marginal Effects From Binary Logistic Regression Models Predicting Negative COVID-19 Experiences Among Working-Age Adults (25–64) With ADHD Versus Without ADHD
| Model 1 | Model 2 | Model 3 | |
|---|---|---|---|
|
| |||
| AME (95% CI) | AME (95% CI) | AME (95% CI) | |
|
| |||
| Negative Overall COVID-19 Impact | 0.17*** (0.11, 0.23) | 0.16*** (0.11, 0.22) | 0.15*** (0.09, 0.21) |
| Worsened Financial Situation | 0.06* (0.01, 0.11) | 0.05 (−0.00, 0.11) | 0.02 (−0.03, 0.08) |
| Worsened Physical Health | 0.19*** (0.13, 0.25) | 0.17*** (0.11, 0.23) | 0.14*** (0.08, 0.20) |
| Worsened Mental Health | 0.24*** (0.18, 0.30) | 0.19*** (0.13, 0.25) | 0.16*** (0.10, 0.21) |
| Worsened Relationship with Family | 0.13*** (0.08, 0.18) | 0.10*** (0.06, 0.15) | 0.08** (0.03, 0.12) |
| Worsened Relationship with Friends | 0.15*** (0.09, 0.21) | 0.12*** (0.07, 0.18) | 0.10*** (0.04, 0.16) |
SOURCE: National Wellbeing Survey, 2023 (N= 5,725). NOTES: ADHD = attention-deficit/hyperactivity disorder. Statistical significance:
p < 0.05;
p < 0.01;
p < 0.001. Model 1 = unadjusted model; Model 2 = Model 1 adjusted for demographics, household size, COVID-19 infection history, health insurance status, and health care checkup status; Model 3 = Model 2 plus potential mediators: substance use (smoking status, illicit drug use, prescription medication misuse, marijuana use, heavy drinking) and socioeconomic resources (education, employment, income, marital status). CI = confidence interval; All models were weighted. Full model results for each outcome are presented in Online Appendix Tables 1–6.
Model 2, which adjusts for demographic and other covariates, shows that the ADHD disadvantage holds for all outcomes except worsened financial situation, for which the p-value increased to 0.064. Net of controls, adults with ADHD had a 16-percentage-point higher predicted probability of reporting a negative overall COVID-19 impact, a 17-percentage-point higher probability of worsened physical health, a 19-percentage-point higher probability of worsened mental health, a 10-percentage-point higher probability of worsened relationships with family, and a 12-percentage-point higher probability of worsened relationships with friends, compared to adults without ADHD.
The addition of substance use and socioeconomic resource mediators in Model 3 only partially attenuated these differences. In Model 3 (full results presented in Online Appendix Tables 1-6), adults with ADHD had a 15-percentage-point higher predicted probability of reporting a negative overall COVID-19 impact, a 14-percentage-point higher probability of worsened physical health, a 16-percentage-point higher probability of worsened mental health, an 8-percentage-point higher probability of worsened relationships with family, and a 10-percentage-point higher probability of worsened relationships with friends, compared to adults without ADHD. Substance use and socioeconomic resources were significantly associated with each outcome to varying degrees. Current smokers had a higher predicted probability of both negative overall COVID-19 impact and worsened family relationships. Heavy drinking was associated with a higher predicted probability of reporting worsened mental health and family relationships. Illicit drug use was associated with a higher predicted probability of reporting worsened physical and mental health. Marijuana use was associated with a higher probability of all outcomes except overall COVID-19 impact. In terms of socioeconomic resources, contrary to expectations, those with an associate degree/some college or bachelor’s degree or more, respectively, were more likely to report that COVID-19 had an overall negative impact on their lives compared to those with less than a high school degree. Employed adults were less likely to report worsened financial situations, physical health, and mental health. Higher household income was associated with a lower probability of reporting both worsened financial situation and worsened family relationships. In terms of marital status, adults who were previously married (widowed/divorced/separated) had a higher probability of reporting worsened mental health and family relationships than those who were married.
3.3. KHB Decomposition
Table 3 presents the results of the KHB decomposition analyses examining the net total, direct, and indirect effects of ADHD status on the COVID-19-related experiences, accounting for the roles of substance use and socioeconomic resources in these relationships. Substance use and socioeconomic resources contributed to ADHD status differences across all outcomes (indirect effects). Specifically, the inclusion of substance use and socioeconomic resources collectively contributed 9.5% to the ADHD disadvantage for overall COVID-19 impact, 16–17% for worsened physical health, mental health, and relationships with friends, and 23.8% for worsened relationships with family. While 50.3% of the total association between ADHD and worsened financial impact observed in Model 2 was accounted for by substance use and socioeconomic resources, the ADHD difference in financial impact was very small (only 5 percentage points) and statistically non-significant. Collectively, these findings suggest that ADHD was associated with greater vulnerability to pandemic-related adversities, partly driven by differences in substance use and socioeconomic resources.
Table 3.
KHB Decomposition Tests: Total, Direct, and Indirect Effects of ADHD on COVID-19-Related Experiences
| Outcome | OR (Total Effect) | 95% CI | OR (Direct Effect) | 95% CI | OR (Indirect Effect) | 95% CI | Contributed % |
|---|---|---|---|---|---|---|---|
|
| |||||||
| Negative Overall Impact | 2.00*** | (1.56, 2.57) | 1.87*** | (1.45, 2.41) | 1.07* | (1.00, 1.14) | 9.49 |
| Worsened Financial Situation | 1.27 | (0.99, 1.64) | 1.13 | (0.87, 1.46) | 1.13** | (1.06, 1.21) | 50.34 |
| Worsened Physical Health | 2.27*** | (1.74, 2.97) | 1.97*** | (1.49, 2.59) | 1.15*** | (1.07, 1.24) | 17.38 |
| Worsened Mental Health | 2.46*** | (1.89, 3.19) | 2.12*** | (1.63, 2.75) | 1.16*** | (1.08, 1.25) | 16.54 |
| Worsened Relationship with Family | 2.03*** | (1.52, 2.71) | 1.71*** | (1.28, 2.30) | 1.18*** | (1.09, 1.28) | 23.84 |
| Worsened Relationship with Friends | 2.03*** | (1.52, 2.72) | 1.82*** | (1.34, 2.46) | 1.12** | (1.04, 1.20) | 15.69 |
SOURCE: National Wellbeing Survey, 2023 (N= 5,725). NOTES: ADHD = attention-deficit/hyperactivity disorder. OR = odds ratio; CI = confidence interval. Statistical significance:
p < 0.05;
p < 0.01;
p < 0.001. The indirect effects reflect the roles of substance use and socioeconomic resources. All models were weighted.
Table 4 presents the relative contribution of each substance use behavior and socioeconomic resource to each indirect effect reported in Table 3. Contributions for each sum to 100%. Illicit drug use and marijuana use together accounted for the largest share, by far, of the indirect effects across all outcomes. Prescription medication misuse contributed to ADHD status differences in overall COVID-19 impact and relationships with friends. Smoking status contributed to ADHD status differences in overall COVID-19 impact and relationships with family. Employment status contributed to ADHD status differences in physical and mental health and relationships with friends. Higher education had a suppressor effect in several models, particularly for overall COVID-19 impact, physical and mental health, and relationships with family and friends. This is because adults with ADHD have lower levels of education, but participants with higher education generally reported worse COVID-19 impacts. Finally, household income of $75,000+ contributed to ADHD status differences in overall COVID-19 impact.
Table 4.
KHB Decomposition Analysis: Specific Substance Use and Socioeconomic Resource Contributions to the Indirect Effects of ADHD Status on Negative COVID-19-Related Experiences
| Contributor | Negative Overall Impact (%) | Worsened Financial Situation (%) | Worsened Physical Health (%) | Worsened Mental Health (%) | Worsened Relationship with Family (%) | Worsened Relationship with Friends (%) |
|---|---|---|---|---|---|---|
|
| ||||||
| Substance use | ||||||
| Illicit drug use | +36.77 | +17.50 | +36.38 | +34.79 | +7.41 | +41.59 |
| Prescription medication misuse | +26.25 | −1.31 | −4.76 | −0.29 | +8.20 | +9.01 |
| Marijuana use | +19.55 | +38.75 | +32.29 | +51.34 | +41.70 | +57.14 |
| Former smoker | +9.38 | −6.83 | +5.06 | −3.12 | +14.58 | −7.10 |
| Current smoker | +20.20 | −2.38 | +2.06 | −2.91 | +12.58 | +4.07 |
| Heavy drinking | +1.11 | −1.65 | −2.62 | −3.65 | −3.97 | −3.20 |
|
Education (ref=less than high school) | ||||||
| High school | +3.25 | +0.20 | +0.03 | −0.85 | +0.64 | +1.30 |
| Associate degree/ some college | +18.44 | +2.64 | +3.83 | +0.68 | +2.80 | −0.46 |
| Bachelor`s degree or more | −49.94 | +1.70 | −11.28 | −5.01 | −7.85 | −21.45 |
|
Employment Status (ref= unemployed) | ||||||
| Employed | +10.51 | +28.84 | +30.67 | +19.56 | +5.10 | +11.94 |
|
Household Income in 2022 (ref=less than $25,000) | ||||||
| $25K–$49K | −0.56 | −0.10 | +0.17 | +0.00 | +0.33 | −0.39 |
| $50K–$74K | +2.22 | +4.07 | +1.43 | +1.19 | +4.61 | +0.20 |
| $75K+ | +10.74 | +14.59 | +5.49 | +2.03 | +7.44 | +0.63 |
|
Marital status (ref=married/partnered) | ||||||
| Widowed, divorced, or separated | −5.18 | +3.88 | +0.47 | +6.60 | +11.19 | +6.21 |
| Never married | −2.73 | +0.09 | +0.77 | −0.35 | −4.75 | +0.52 |
| Total % | 100% | 100% | 100% | 100% | 100% | 100% |
SOURCE: National Wellbeing Survey, 2023 (N= 5,725). NOTES: ADHD = attention-deficit/hyperactivity disorder. Percentages represent the relative contribution of each contributor to the total indirect effect shown in Table 3. Values represent the % contribution to the indirect (mediated) effect based on the KHB decomposition. A positive % indicates that the factor explains part of (reduces, mediates) the association between ADHD status and the negative COVID-19-related outcome. A negative % reflects a suppressor effect, meaning that adjusting for the factor increases the observed association between ADHD status and the outcome. All analyses were weighted.
3.4. Sensitivity Analyses
Results from models using listwise deletion were consistent with those using imputed covariates (presented above) for associations between ADHD status and the six outcomes (Online Appendix Tables 7–8). Sensitivity analyses that included participants aged 18–24 also yielded results comparable to those presented above (Online Appendix Tables 9–12). Across all outcomes, illicit drug use and marijuana use were the largest contributors to ADHD differences in outcomes (Online Appendix Table 12).
4. Discussion
This study examined self-reported ADHD diagnosis status differences in six COVID-19 related outcomes among U.S. adults ages 25–64. Consistent with findings from non-U.S. studies, U.S. adults with ADHD were more likely to report negative COVID-19-related outcomes across several domains (Hollingdale et al., 2021; Pollak et al., 2022). Specifically, net of potentially confounding factors, adults with ADHD had a greater likelihood of reporting that COVID-19 had an overall negative impact on their lives, and adverse effects on their physical health, mental health, relationships with family, and relationships with friends, compared to adults without ADHD. These findings align with the stress proliferation hypothesis, which posits that a primary stressor of sufficient magnitude and/or duration can generate or reinforce secondary stressors (Pearlin & Bierman, 2012) and undermine stress-buffering support and coping resources.
To assess whether the disproportionate negative effects of COVID-19 among adults with ADHD were explained by substance use and/or socioeconomic resources, we conducted Karlson–Holm–Breen (KHB) decomposition analyses. As expected, accounting for these factors attenuated associations between ADHD status and adverse pandemic experiences, with their combined contributions ranging from 9.5% to 23.8% of observed differences across outcomes. Although neither set of factors fully accounted for the ADHD disadvantage, examining the contributions of specific components proved informative.
Among all factors in the decomposition, illicit drug and marijuana use were the strongest contributors to ADHD-related disparities in COVID-19 experiences, consistent with prior research showing that adults with ADHD are more likely to use these substances as coping strategies (Danielsson et al., 2024; Dhamija et al., 2023). The pandemic context may have compounded this vulnerability in several ways. Nationwide shortages of prescription stimulants and changes in prescribing practices created barriers to continuity of care, potentially leading some individuals with ADHD to skip doses, switch medications, or struggle to refill prescriptions (Rao et al., 2025; Staley et al., 2024). These difficulties likely increased stress and may have promoted self-medication through illicit drug and marijuana use or misuse of prescribed medications. More broadly, given higher baseline rates of use of illicit drugs and misuse of prescription medications among adults with ADHD (London et al. 2025b), pandemic-related disruptions to daily routines and social environments may have further intensified distress and contributed to negative outcomes. While testing these specific pathways is beyond the scope of the current study, future research could investigate how disruptions to medication access, illicit drug availability, and use environments affect the wellbeing of adults with ADHD.
Among the socioeconomic resource factors we considered in the decomposition analysis, employment status was the largest contributor to the observed ADHD disadvantage. Employment status contributed notably to explaining the ADHD disadvantage in physical health, mental health, and relationships with friends. During the pandemic, employment experiences varied widely: some workers were considered essential and faced the challenge of leaving home, maintaining safety at work, and minimizing risk to family members, while others worked remotely and struggled to balance professional demands with family responsibilities and household distractions. These different work conditions may have affected adults with ADHD differently than adults without ADHD, contributing to their disproportionately negative pandemic experiences. From a stress proliferation perspective, employment status may have shaped both exposure to stressors and access to coping resources during the pandemic. ADHD-related challenges, including difficulties with executive functioning and emotional regulation, may have increased vulnerability to employment instability and elevated psychological strain. Employment is also the gatekeeper to access to key resources, including income, social support, healthcare access, a sense of mastery, and social role identity, all of which may buffer the impact of stress. Thus, disrupted access to these resources during the pandemic may have disproportionately affected individuals with ADHD. The cross-sectional nature of the NWS data does not allow us to test any of these potential explanations. We encourage future research that can disentangle some of these pathways.
Interestingly, and contrary to expectations, individuals with higher educational attainment reported worse COVID-19 experiences, net of other variables. This finding aligns with national studies showing that Americans with higher education experienced larger increases in depressive symptoms and declines in life satisfaction during the pandemic (Wanberg et al., 2020). One possible explanation is that those with higher education held stronger expectations of socioeconomic stability and control; disruptions to these expectations during the pandemic may have heightened stress and led to more negative evaluations of their experiences (Wanberg et al., 2020). Individuals with higher educations may also have higher expectations of agency, freedom of movement, and choice, and thus may have experienced externally imposed, pandemic-related constraints on their agency more negatively than people with lower educational attainment and different expectations.
As noted above, substance use and socioeconomic resources explained between 9.5% and 23.8% of the observed ADHD disparities in COVID-19 experiences. This indicates that there are other unobserved mechanisms that also contributed to these differences. Several pandemic-related disruptions may have been particularly challenging for adults with ADHD. Changes in living and working environments, including increased crowding, noise, distraction, sleep disruption, and interpersonal conflict, may have been especially difficult for individuals already managing ADHD-related difficulties with attention and self-regulation. Similarly, restrictions on recreational and social activities outside the home, such as going to the gym, socializing with friends, and maintaining intimate relationships, may have eliminated key outlets that adults with ADHD relied on to manage stress and maintain wellbeing. Beyond these environmental disruptions, the stress proliferation model suggests that individuals with marginalized identities, such as those with ADHD, experience more discrimination and stigma (Ciciurkaite et al., 2022). Indeed, individuals with ADHD commonly report discrimination and stigma in both educational and workplace settings (Follmer & Jones, 2018; Metzger & Hamilton, 2021), and it is possible that the uncertainties and disruptions of the pandemic amplified these experiences. Heightened stigma and social exclusion could have compounded existing vulnerabilities, contributing to poorer pandemic outcomes. Future research should examine how these different experiences may have interacted to shape the pandemic and post-pandemic wellbeing of adults with ADHD.
The COVID-19 pandemic functioned as a macro-stressor that amplified pre-existing disadvantages – a dynamic with relevance extending well beyond pandemic-specific circumstances. The stress process model posits that major disruptions generate “constellations of secondary stressors,” which disproportionately affect already-disadvantaged populations (Pearlin & Bierman, 2012). Our findings are consistent with this framework. ADHD status was associated with negative outcomes overall and across health and social relationship domains; differences in substance use and socioeconomic resources partially, but not fully, accounted for these disparities. These patterns suggest that adults with ADHD may be systematically more vulnerable to large-scale social and institutional disruptions, with the pandemic serving as a particularly visible illustration of this vulnerability. Pandemic-related challenges, including less structure in daily routines, changes in social interactions, and limited access to healthcare services, mirror stressors that adults with ADHD may face during other periods of major life transitions or instability, such as entering college, transitioning to independent living, marrying or divorcing, becoming a parent, changing jobs, and navigating economic downturns. That ADHD-related disparities emerged across multiple life domains when social systems and routines were disrupted underscores the importance of considering how social and institutional arrangements shape outcomes for adults with ADHD, particularly during periods of instability. More broadly, our findings point to the need for policies and support systems that account for differential vulnerability during large-scale disruptions – whether pandemics, economic recessions, natural disasters, or other societal upheavals. Proactive, targeted supports during such periods may help reduce the kinds of adverse outcomes that might be expected based on the evidence presented in this paper. Investigating whether and why these kinds of life-course disruptions are experienced more negatively by adults with ADHD than adults without ADHD is an important direction for future research.
Importantly, the disparities documented here are not inherent to ADHD itself. They reflect the interaction between ADHD-related characteristics and social structures that often fail to accommodate neurodevelopmental diversity. Many adults with ADHD develop effective coping strategies and demonstrate resilience, particularly in supportive environments. Our findings underscore the need not only for crisis-specific interventions but also for structural changes that better support neurodivergent adults before disruptions occur.
4.1. Limitations
There are some limitations to the study that point to additional directions for future research. First, the cross-sectional design does not permit definitive statements about causal ordering. While reverse causality is possible, the observed patterns are consistent with prior research on ADHD and stress (Barra et al., 2021). Pandemic-related stress has been linked to symptoms commonly found among people with ADHD, including emotional dysregulation, reduced cognitive functioning, impulsivity, and inattention (Auro et al., 2024). ADHD diagnoses did increase during the pandemic largely via telemedicine (Auro et al., 2024), although most ADHD diagnosis still occurs in childhood and adolescence. Because the NWS does not include information on diagnosis timing, age at onset, current symptoms, functioning, or treatment, it was not possible to determine whether participants were newly diagnosed or had long-standing ADHD. It was also not possible to discern whether they were actively experiencing symptoms at the time of the survey. Consequently, we could not assess how outcomes varied across these dimensions. It is also possible that stress-related re-emergence or exacerbation of ADHD symptoms during this period contributed to the more negative experiences reported by some individuals with ADHD. Relatedly, the cross-sectional nature of our data does not allow us to determine whether substance use behaviors and socioeconomic resources were stable or shifted during the pandemic. However, both are well-documented consequences of ADHD, which supports conceptualizing them as potential mediators of the association between ADHD status and COVID-19 experiences.
Second, the NWS classified ADHD status as a medical condition, which may not capture broader behavioral and educational definitions (Mayes, 2019), or alternative definitions of lived experience originating in the neurodivergent community (Bertilsdotter et al., 2023). Third, although the survey relied on a non-probability sample, the use of weights substantially improves representativeness and comparability with national surveys, such as the National Health Interview Survey. Finally, as an online survey, the NWS may exclude some adults without internet access (Danielsson et al., 2024).
5. Conclusion
The COVID-19 pandemic exacted a disproportionate toll on working-age adults with ADHD, adversely affecting them globally, and with respect to their physical and mental health and social relationships. Because ADHD is often accompanied by intersecting health and socioeconomic disadvantages, individuals with the condition face greater stress exposure and less access to resources—structural vulnerabilities that can become especially pronounced during public health crises. The findings reported in this paper highlight the importance of recognizing how large-scale shocks, like the COVID-19 pandemic, economic recessions, and natural disasters, can contribute to poorer outcomes for people with ADHD via both individual and structural factors. Scholars, policymakers, public health, and clinical professionals should prioritize identifying the resources, supports, and interventions that can mitigate these vulnerabilities.
Supplementary Material
Highlights.
Adults with ADHD reported worse COVID-19 experiences than adults without ADHD
Outcomes were worse overall and across health and social relationship domains
ADHD disadvantages partly accounted for by substance use and socioeconomic resources
Illicit drug and marijuana use account for the largest share of the indirect effects
ADHD disparities persisted after substance use and socioeconomic resource adjustments
Funding:
This study was funded in part by a grant (U01DA055972) from the National Institute on Drug Abuse (NIDA) and support from the Syracuse University Lerner Center for Public Health Promotion and Population Health. The findings do not necessarily represent the views of these funders.
Footnotes
Potential conflicts of interest: Vaitsiakhovich – none; Monnat – none; London – none; Landes – none
Financial interests: None
Contributor Information
Nastassia Vaitsiakhovich, Department of Sociology and Lerner Center for Public Health Promotion and Population Health, Maxwell School of Citizenship and Public Affairs, Syracuse University, 044 Eggers Hall, Syracuse, NY, 13244.
Shannon M. Monnat, Department of Sociology, Lerner Center for Public Health Promotion and Population Health, Center for Policy Research, Maxwell School of Citizenship and Public Affairs, Syracuse University, 426 Eggers Hall, Syracuse, NY, 13244.
Andrew S. London, Department of Sociology, Aging Studies Institute, and Lerner Center for Public Health Promotion and Population Health, Maxwell School of Citizenship and Public Affairs, Syracuse University, 200 Eggers Hall, Syracuse, NY, 13244.
Scott D. Landes, Department of Sociology, Aging Studies Institute, and Lerner Center for Public Health Promotion and Population Health, Maxwell School of Citizenship and Public Affairs, Syracuse University, 314 Lyman Hall, Syracuse, NY, 13244.
References
- Allison PD (2001). Missing data. SAGE Publications. [Google Scholar]
- Angrist JD, & Pischke J-S. (2009). Mostly harmless econometrics: An empiricist’s companion. Princeton University Press. [Google Scholar]
- Auro K, Holopainen I, Perola M, Havulinna AS, & Raevuori A (2024). Attention-deficit/hyperactivity disorder diagnoses in Finland during the COVID-19 pandemic. JAMA Network Open, 7(6), e2418204. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Barra S, Grub A, Roesler M, Retz-Junginger P, Philipp F, & Retz W (2021). The role of stress coping strategies for life impairments in ADHD. Journal of Neural Transmission, 128(7), 981–992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bertilsdotter Rosqvist H, Hultman L, Österborg Wiklund S, Nygren A, Storm P, & Sandberg G (2023). Intensity and variable attention: Counter narrating ADHD, from ADHD deficits to ADHD difference. The British Journal of Social Work, 53(8), 3647–3664. [Google Scholar]
- Biswas M, Rahaman S, Biswas TK, Haque Z, & Ibrahim B (2021). Association of sex, age, and comorbidities with mortality in COVID-19 patients: A systematic review and meta-analysis. Intervirology, 64(1), 36–47. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bridgland VME, Moeck EK, Green DM, Swain TL, Nayda DM, Matson LA, Hutchison NP, & Takarangi MKT (2021). Why the COVID-19 pandemic is a traumatic stressor. PLoS ONE, 16(1), 1–15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Braksmajer A, & London AS (2021). “It’s history in the making all around us”: Examining COVID-19 through the lenses of HIV and epidemic history. Culture, Health & Sexuality, 23(11), 1500–1515. [DOI] [PubMed] [Google Scholar]
- Brockett AT, Pribut HJ, Vázquez D, & Roesch MR (2018). The impact of drugs of abuse on executive function: Characterizing long-term changes in neural correlates following chronic drug exposure and withdrawal in rats. Learning and Memory, 25(9), 461–473. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Capasso A, Kim S, Ali SH, Jones AM, DiClemente RJ, & Tozan Y (2022). Socioeconomic predictors of COVID-19-related health disparities among United States workers: A structural equation modeling study. PLOS Global Public Health, 2(2), e0000117. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Carliner H, Brown QL, Sarvet AL, & Hasin DS (2017). Cannabis use, attitudes, and legal status in the U.S.: A review. Preventive Medication, 104, 13–23. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ciciurkaite G, Marquez-Velarde G, & Brown RL (2022). Stressors associated with the COVID-19 pandemic, disability, and mental health: Considerations from the Intermountain West. Stress and Health, 38(2), 304–317. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Connolly RD, Lamont A, & Speed D (2023). Perceived social support on the relationship between ADD/ADHD and both anxious and depressive symptoms among Canadian adults. Journal of Attention Disorders, 27(3), 283–293. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Danielsson K, Arnberg FK, & Bondjers K (2024). Coping strategies and symptoms of adjustment disorder among adults with attention deficit hyperactivity disorder (ADHD) during the COVID-19 pandemic. PLoS ONE, 19(8), 1–13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dhamija D, Bello AO, Khan AA, Gutlapalli SD, Sohail M, Patel PA, … & Patel P (2023). Evaluation of efficacy of cannabis use in patients with attention deficit hyperactivity disorder: a systematic review. Cureus, 15(6), e40969. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Follmer KB, & Jones KS (2018). Mental illness in the workplace: An interdisciplinary review and organizational research agenda. Journal of Management, 44(1), 325–351. [Google Scholar]
- Gimbach S, Vogel D, Fried R, Faraone SV, Banaschewski T, Buitelaar J, … & Ammer R (2024). ADHD medicine consumption in Europe after COVID-19: catch-up or trend change?. BMC Psychiatry, 24(1), 112. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Graham JW, Olchowski AE, & Gilreath TD (2007). How many imputations are really needed? Some practical clarifications of multiple imputation theory. Prevention Science, 8(3), 206–213. [DOI] [PubMed] [Google Scholar]
- Holborn T, Schifano F, Smith E, & Deluca P (2025). The use of novel stimulants in ADHD self-medication: A mixed methods analysis. Brain Sciences, 15(3), 292. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hollingdale J, Adamo N, & Tierney K (2021). Impact of COVID-19 for people living and working with ADHD: A brief review of the literature. AIMS Public Health, 8(4), 581–597. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kohler U, Karlson KB, & Holm A (2011). Comparing coefficients of nested nonlinear probability models. The Stata Journal, 11(3), 420–438. [Google Scholar]
- Landes SD, & London AS (2021). Self-reported ADHD and adult health in the United States. Journal of Attention Disorders, 25(1), 3–13. [DOI] [PubMed] [Google Scholar]
- Landes SD, Finan JM, & Turk MA (2022). COVID-19 mortality burden and comorbidity patterns among decedents with and without intellectual and developmental disability in the U.S. Disability and Health Journal, 101376. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lensing MB, Zeiner P, Sandvik L, & Opjordsmoen S (2015). Quality of life in adults aged 50+ with ADHD. Journal of Attention Disorders, 19(5), 405–413. [DOI] [PubMed] [Google Scholar]
- Leonard KE, & Eiden RD (2007). Marital and family processes in the context of alcohol use and alcohol disorders. Annual Review of Clinical Psychology, 3, 285–310. [DOI] [PMC free article] [PubMed] [Google Scholar]
- London AS, Monnat SM, & Gutin I (2025a). Self-reported ADHD diagnosis status among working-age adults in the United States: Evidence from the 2023 National Wellbeing Survey. Journal of Attention Disorders, 29(6), 399–410. [DOI] [PMC free article] [PubMed] [Google Scholar]
- London AS, Antshel KM, Grove J, Gutin I, & Monnat SM (2025b). Self-reported ADHD diagnosis and illicit drug use and prescription medication misuse among U.S. Working-Age Adults. Journal of Attention Disorders, 29(14): 1355–1366. [DOI] [PMC free article] [PubMed] [Google Scholar]
- López-Pinar C, Martínez-Sanchís S, Carbonell-Vayá E, Fenollar-Cortés J, & Sánchez-Meca J (2018). Long-term efficacy of psychosocial treatments for adults with attention-deficit/hyperactivity disorder: A meta-analytic review. Frontiers in Psychology, 9, Article 638. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mayes R (2019). ADHD, or the Medicalization of Social Problems. American Journal of Public Health, 109(9), 1154–1155. [Google Scholar]
- Merzon E, Weiss MD, Cortese S, Rotem A, Schneider T, Craig SG, Vinker S, Golan Cohen A, Green I, Ashkenazi S, Weizman A, & Manor I (2021). The association between ADHD and the severity of COVID-19 infection. Journal of Attention Disorders, 26(4), 491–501. [DOI] [PubMed] [Google Scholar]
- Metzger AN, & Hamilton LT (2021). The stigma of ADHD: Teacher ratings of labeled students. Sociological Perspectives, 64(2), 258–279. [Google Scholar]
- Monnat SM, & Gutin I (2025). National Wellbeing Survey (NWS), 2023 Methodology Report. Syracuse University, Lerner Center for Public Health Promotion and Population Health. https://www.maxwell.syr.edu/research/lerner-center/health-research/national-wellbeing-survey [Google Scholar]
- Monnat SM, Zhang X, Wiemers E, Wolf DA, Montez JK (2023). National Wellbeing Survey, United States, 2023. Syracuse University Lerner Center for Public Health Promotion and Population Heath; (accessed via a data use agreement). [Google Scholar]
- Öncü BK, & Kişlak ŞT (2022). Marital adjustment and marital conflict in individuals diagnosed with ADHD and their spouses. Archives of Neuropsychiatry, 59(2), 127. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pearlin LI, & Bierman A (2012). Current issues and future directions in research into the stress process. In Handbook of the sociology of mental health (pp. 325–340). Dordrecht: Springer Netherlands. [Google Scholar]
- Pearlin LI, Menaghan EG, & Lieberman MA (1981). The stress process. Journal of Health and Social Behavior, 22(4), 337–356. [PubMed] [Google Scholar]
- Pendergrast CB, & Monnat SM (2022). Perceived impacts of COVID-19 on wellbeing among U.S. working-age adults with ADL difficulty. Disability and Health Journal, 101337. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pollak Y, Shoham R, Dayan H, Gabrieli-Seri O, & Berger I (2022). Symptoms of ADHD predict lower adaptation to the COVID-19 outbreak: Financial decline, low adherence to preventive measures, psychological distress, and illness-related negative perceptions. Journal of Attention Disorders, 26(5), 735–746. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Quenneville AF, Kalogeropoulou E, Nicastro R, Weibel S, Chanut F, & Perroud N (2022). Anxiety disorders in adult ADHD: A frequent comorbidity and a risk factor for externalizing problems. Psychiatry Research, 310, 114423. [DOI] [PubMed] [Google Scholar]
- Rana JS, Chi FW, Acquah I, & Sterling SA (2025). Unhealthy alcohol use and risk of coronary heart disease among young and middle-aged adults. American Journal of Preventive Cardiology, 21, 100947. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rao V, Lanni S, Yule AM, McCabe SE, Veliz PT, Schepis TS, & Wilens TE (2025). Telehealth prescribing of stimulants for ADHD and associated risk for later stimulant and substance use disorders. American Journal of Psychiatry, 182(8), 779–788. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rosenberg CE (1989). What is an epidemic? AIDS in historical perspective. Daedalus, 18(2), 1–17. [PubMed] [Google Scholar]
- Schein J, Adler LA, Childress A, Gagnon-Sanschagrin P, Davidson M, Kinkead F, Cloutier M, Guérin A, & Lefebvre P (2022). Economic burden of attention-deficit/hyperactivity disorder among adults in the United States: A societal perspective. Journal of Managed Care & Specialty Pharmacy, 28(2), 168–179. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Segal D, Mashal N, & Shalev L (2015). Semantic conflicts are resolved differently by adults with and without ADHD. Research in Developmental Disabilities, 47, 416–429. [DOI] [PubMed] [Google Scholar]
- Settersten RA, Bernardi L, Härkönen J, Antonucci TC, Dykstra PA, Heckhausen J, Kuh D, Mayer KU, Moen P, Mortimer JT, Mulder CH, Smeeding TM, van der Lippe T, Hagestad GO, Kohli M, Levy R, Schoon I, & Thomson E (2020). Understanding the effects of COVID-19 through a life course lens. Advances in Life Course Research, 45, 100360. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sibley MH, Swanson JM, Arnold LE, Hechtman LT, Owens EB, Stehli A, Abikoff H, Hinshaw SP, Molina BSG, Mitchell JT, Jensen PS, Howard AL, Lakes KD, & Pelham WE (2017). Defining ADHD symptom persistence in adulthood: Optimizing sensitivity and specificity. Journal of Child Psychology and Psychiatry, 58(6), 655–662. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Staley BS, Robinson LR, Claussen AH, Katz SM, Danielson ML, Summers AD, Sherry, Farr L, Blumberg SJ, & Tinker SC (2024). Attention-deficit/hyperactivity disorder diagnosis, treatment, and telehealth use in adults—National Center for Health Statistics Rapid Surveys System, United States, October–November 2023. Morbidity and Mortality Weekly Report, 73(40), 890–895. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Swift KD, Sayal K, & Hollis C (2014). ADHD and transitions to adult mental health services: A scoping review. Child: Care, Health and Development, 40(6), 775–786. [DOI] [PubMed] [Google Scholar]
- Talbert RD, & Hearne BN (2022). Race/ethnicity, Household Employment Loss, and Psychological Distress during COVID-19: Examining the Moderating Role of Marital Status. Sociological Imagination, 58(2), 65–81. [Google Scholar]
- Tuan W-J, Babinski DE, Rabago DP, & Zgierska AE (2022). Treatment with stimulants and the risk of COVID-19 complications in adults with ADHD. Brain Research Bulletin, 187, 155–161. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Turner S, Mota N, Bolton J, & Sareen J (2018). Self-medication with alcohol or drugs for mood and anxiety disorders: A narrative review of the epidemiological literature. Depression and Anxiety, 35(9), 851–860. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Varrasi S, Boccaccio FM, Guerrera CS, Platania GA, Pirrone C, & Castellano S (2023). Schooling and occupational outcomes in adults with ADHD: Predictors of success and support strategies for effective learning. Education Sciences, 13(1), 1–17. [Google Scholar]
- Wanberg CR, Csillag B, Douglass RP, Zhou L, & Pollard MS (2020). Socioeconomic status and well-being during COVID-19: A resource-based examination. Journal of Applied Psychology, 105(12), 1382–1396. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wymbs BT, Canu WH, Sacchetti GM and Ranson LM (2021), Adult ADHD and romantic relationships: What we know and what we can do to help. J Marital Fam Ther, 47: 664–681. [DOI] [PubMed] [Google Scholar]
- Wysocki AC, Lawson KM, & Rhemtulla M (2022). Statistical control requires causal justification. Advances in Methods and Practices in Psychological Science, 5(2), Article 25152459221095823. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
